Literature DB >> 17650357

Multicenter study of clinical features of sudden-onset versus slower-onset asthma exacerbations requiring hospitalization.

Venktesh R Ramnath1, Sunday Clark, Carlos A Camargo.   

Abstract

BACKGROUND: Asthma exacerbations differ in their speed of symptom onset.
OBJECTIVE: To characterize and compare demographic factors, clinical risk factors, and clinical outcomes among hospitalized patients who presented with sudden-onset (<or= 3 h) versus slower-onset asthma exacerbations, across a wide age range.
METHODS: We reviewed the medical records of a random sample of 1,294 patients, ages 2-54 years, admitted in 30 United States hospitals, for acute asthma from January 1999 to May 2000.
RESULTS: Data on duration of symptoms were available for 1,260 (97%) of the patients. Seventy-two patients (6%) had sudden-onset exacerbations. Sudden-onset patients were older than slower-onset patients (30 y vs 19 y, p = 0.03) but did not differ by other sociodemographic characteristics. Markers of chronic asthma severity were similar between the groups. The sudden-onset patients were more likely to present to the emergency department between midnight and 8:00 am, to require intubation, and to be admitted to the intensive care unit (all p < 0.01). The higher risk of intensive care unit admission remained significant even after adjustment for 6 potential confounders (odds ratio 2.5, 95% confidence interval 1.3-4.9). However, hospital stay was shorter in the sudden-onset patients (2.0 d vs 2.7 d, p = 0.01). There was no difference in peak expiratory flow at hospital discharge.
CONCLUSIONS: The sudden-onset patients were older and they more commonly presented to the emergency department between midnight and 8:00 am with severe exacerbations that required intubation and intensive care unit admission. However, the sudden-onset group was discharged from the hospital earlier.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17650357

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  6 in total

1.  The Saudi Initiative for Asthma - 2019 Update: Guidelines for the diagnosis and management of asthma in adults and children.

Authors:  Mohamed S Al-Moamary; Sami A Alhaider; Abdullah A Alangari; Mohammed O Al Ghobain; Mohammed O Zeitouni; Majdy M Idrees; Abdullah F Alanazi; Adel S Al-Harbi; Abdullah A Yousef; Hassan S Alorainy; Mohamed S Al-Hajjaj
Journal:  Ann Thorac Med       Date:  2019 Jan-Mar       Impact factor: 2.219

2.  Outcome of children with life-threatening asthma necessitating pediatric intensive care.

Authors:  Kam-Lun Hon; Wing-Sum Winnie Tang; Ting-Fan Leung; Kam-Lau Cheung; Pak-Cheung Ng
Journal:  Ital J Pediatr       Date:  2010-07-06       Impact factor: 2.638

Review 3.  Acute Severe Asthma in Adolescent and Adult Patients: Current Perspectives on Assessment and Management.

Authors:  Eirini Kostakou; Evangelos Kaniaris; Effrosyni Filiou; Ioannis Vasileiadis; Paraskevi Katsaounou; Eleni Tzortzaki; Nikolaos Koulouris; Antonia Koutsoukou; Nikoletta Rovina
Journal:  J Clin Med       Date:  2019-08-22       Impact factor: 4.241

4.  Methylxanthine use for acute asthma in the emergency department in Japan: a multicenter observational study.

Authors:  Miki Morikawa; Yusuke Hagiwara; Koichiro Gibo; Tadahiro Goto; Hiroko Watase; Kohei Hasegawa
Journal:  Acute Med Surg       Date:  2019-04-01

5.  Nocturnal emergency department visits, duration of symptoms and risk of hospitalisation among adults with asthma exacerbations: a multicentre observational study.

Authors:  Hideto Yasuda; Yusuke Hagiwara; Hiroko Watase; Kohei Hasegawa
Journal:  BMJ Open       Date:  2016-08-12       Impact factor: 2.692

6.  The Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children.

Authors:  Mohamed S Al-Moamary; Sami A Alhaider; Majdy M Idrees; Mohammed O Al Ghobain; Mohammed O Zeitouni; Adel S Al-Harbi; Abdullah A Yousef; Hussain Al-Matar; Hassan S Alorainy; Mohamed S Al-Hajjaj
Journal:  Ann Thorac Med       Date:  2016 Jan-Mar       Impact factor: 2.219

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.